Category: St. Jude Medical
MassDevice.com looks at the internet chatter surrounding the medical device industry with some of most searched-for companies of the last month.
MassDevice.com looked at some of the most talked-about medical device companies, based on trends in U.S. Google searches for the last 30 days.
Volcano agrees that St. Jude Medical isn't infringing a pair of its fractional flow reserve patents after a court ruling doesn't go its way, but vows to appeal.
Johnson & Johnson's Biosense Webster subsidiary is the 1st to the U.S. market with a force-sensing ablation catheter for atrial fibrillation, the ThermoCool SmartTouch device.
Johnson & Johnson's (NYSE:JNJ) Biosense Webster subsidiary said it won pre-market approval from the FDA for its ThermoCool SmartTouch force-sensing ablation catheter, making it the 1st such device to hit the U.S. market.
St. Jude Medical warns physicians of a potential problem with its older pacemaker models when performing electrocautery procedures.
St. Jude Medical (NYSE:STJ) sent a letter to physicians late last month warning of the potential for problems with its older pacemakers during surgical procedures using electrocautery.
Medtronic touts the 1st U.S. implantation in the investigational device exemption trial of its Micra leadless pacemaker.
Medtronic (NYSE:MDT) said the 1st patient in a clinical trial of its its Micra pacemaker was implanted with the vitamin-sized device, which does not use wires threaded through blood vessels to regulate heart rhythm.
Medtronic's most recent quarterly results suggest that the medtech monolith could be losing ground to arch-rivals Boston Scientific and St. Jude Medical in the cardiac rhythm management market.
Revenues from Medtronic's (NYSE:MDT) bread-and-butter cardiac rhythm management and spine segments were down during its fiscal 3rd quarter, suggesting that the world's largest pure-play medical device maker lost share to its rivals during the quarter.